{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:14Z","timestamp":1787032874987,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,22]]},"DOI":"10.7759\/cureus.28256","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T08:10:10Z","timestamp":1661155810000},"source":"Crossref","is-referenced-by-count":1,"title":["Neuropsychiatric Symptoms in a p16-Positive Tongue Carcinoma Patient: An Unexpected Diagnosis"],"prefix":"10.7759","author":[{"given":"Mohamed Iliyas","family":"Sultan Abdul Kader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Suk","family":"Sian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd Razak","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurulwafa","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnil George","family":"Sirimanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Razif","family":"Mohamad Yunus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley DB","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003, 3:330-8. 10.1038\/nrc1074","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5603\/cj.2012.0084","article-title":"5-fluorouracil induced cardiotoxicity: review of the literature","volume":"19","author":"Sorrentino MF","year":"2012","unstructured":"Sorrentino MF, Kim J, Foderaro AE, Truesdell AG. 5-fluorouracil induced cardiotoxicity: review of the literature. Cardiol J. 2012, 19:453-8. 10.5603\/cj.2012.0084","journal-title":"Cardiol J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2002.17.1.73","article-title":"A case of neurotoxicity following 5-fluorouracil-based chemotherapy","volume":"17","author":"Ki SS","year":"2002","unstructured":"Ki SS, Jeong JM, Kim SH, et al.. A case of neurotoxicity following 5-fluorouracil-based chemotherapy. Korean J Intern Med. 2002, 17:73-7. 10.3904\/kjim.2002.17.1.73","journal-title":"Korean J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.v03n0104","article-title":"Mood and cognitive changes during systemic corticosteroid therapy","volume":"3","author":"Brown ES","year":"2001","unstructured":"Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry. 2001, 3:17-21. 10.4088\/pcc.v03n0104","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2001.16.3.328","article-title":"5-fluorouracil-induced leukoencephalopathy in patients with breast cancer","volume":"16","author":"Choi SM","year":"2001","unstructured":"Choi SM, Lee SH, Yang YS, Kim BC, Kim MK, Cho KH. 5-fluorouracil-induced leukoencephalopathy in patients with breast cancer. J Korean Med Sci. 2001, 16:328-34. 10.3346\/jkms.2001.16.3.328","journal-title":"J Korean Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3816\/CCC.2009.n.027","article-title":"A case of 5-fluorouracil-induced acute psychosis","volume":"8","author":"Fora A","year":"2009","unstructured":"Fora A, Alabsi E, Fakih M. A case of 5-fluorouracil-induced acute psychosis. Clin Colorectal Cancer. 2009, 8:166-8. 10.3816\/CCC.2009.n.027","journal-title":"Clin Colorectal Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2007.04.007","article-title":"A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer","volume":"29","author":"Pacchiarotti I","year":"2007","unstructured":"Pacchiarotti I, Mazzarini L, Pellegrini P, et al.. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer. Gen Hosp Psychiatry. 2007, 29:461-3. 10.1016\/j.genhosppsych.2007.04.007","journal-title":"Gen Hosp Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.79","article-title":"High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy","volume":"75","author":"Yeh KH","year":"1997","unstructured":"Yeh KH, Cheng AL. High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy. Br J Cancer. 1997, 75:464-5. 10.1038\/bjc.1997.79","journal-title":"Br J Cancer"},{"key":"ref9","article-title":"Effect of the fluoropyrimidines 5-fluorouracil and doxifluridine on cellular uptake of thiamin","volume":"9","author":"Heier MS","year":"1989","unstructured":"Heier MS, Dornish JM. Effect of the fluoropyrimidines 5-fluorouracil and doxifluridine on cellular uptake of thiamin. Anticancer Res. 1989, 9:1073-7.","journal-title":"Anticancer Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000768","article-title":"Phenotyping of uracil and 5-fluorouracil metabolism using LC-MS\/MS for prevention of toxicity and dose adjustment of fluoropyrimidines","volume":"42","author":"Tafzi N","year":"2020","unstructured":"Tafzi N, Woillard JB, Fleytoux A, Picard N, Marquet P. Phenotyping of uracil and 5-fluorouracil metabolism using LC-MS\/MS for prevention of toxicity and dose adjustment of fluoropyrimidines. Ther Drug Monit. 2020, 42:540-7. 10.1097\/FTD.0000000000000768","journal-title":"Ther Drug Monit"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.11.2248","article-title":"Population study of dihydropyrimidine dehydrogenase in cancer patients","volume":"12","author":"Etienne MC","year":"1994","unstructured":"Etienne MC, Lagrange JL, Dassonville O, et al.. Population study of dihydropyrimidine dehydrogenase in cancer patients. J Clin Oncol. 1994, 12:2248-53. 10.1200\/JCO.1994.12.11.2248","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1666-0","article-title":"5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases","volume":"68","author":"Cordier PY","year":"2011","unstructured":"Cordier PY, Nau A, Ciccolini J, Oliver M, Mercier C, Lacarelle B, Peytel E. 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases. Cancer Chemother Pharmacol. 2011, 68:823-6. 10.1007\/s00280-011-1666-0","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3816\/ccc.2004.n.018","article-title":"Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration","volume":"4","author":"Ezzeldin H","year":"2004","unstructured":"Ezzeldin H, Diasio R. Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration. Clin Colorectal Cancer. 2004, 4:181-9. 10.3816\/ccc.2004.n.018","journal-title":"Clin Colorectal Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-4347(97)00253-3","article-title":"Semi-automated radioassay for determination of dihydropyrimidine dehydrogenase (DPD) activity. Screening cancer patients for DPD deficiency, a condition associated with 5-fluorouracil toxicity","volume":"696","author":"Johnson MR","year":"1997","unstructured":"Johnson MR, Yan J, Shao L, Albin N, Diasio RB. Semi-automated radioassay for determination of dihydropyrimidine dehydrogenase (DPD) activity. Screening cancer patients for DPD deficiency, a condition associated with 5-fluorouracil toxicity. J Chromatogr B Biomed Sci Appl. 1997, 696:183-191. 10.1016\/s0378-4347(97)00253-3","journal-title":"J Chromatogr B Biomed Sci Appl"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105695-neuropsychiatric-symptoms-in-a-p16-positive-tongue-carcinoma-patient-an-unexpected-diagnosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:38:21Z","timestamp":1707489501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105695-neuropsychiatric-symptoms-in-a-p16-positive-tongue-carcinoma-patient-an-unexpected-diagnosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.28256","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,22]]}}}